Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others.
The market is driven by factors such as growing incidence of cardiac disorders, technological advancements, patient awareness, and increasing number of unmet medical needs in developing and underdeveloped countries. Conversely, the market is hampered by limited insurance coverage options; high cost of these devices, especially in developing nations; and preference for drugs over treatment devices. However, the development of new MRI-labeled devices and growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide opportunities for growth of cardiac monitoring & cardiac rhythm management industry during the forecast period.
The global Cardiac Monitoring & Cardiac Rhythm Management market is valued at 21400 million US$ in 2018 is expected to reach 38300 million US$ by the end of 2025, growing at a CAGR of 7.6% during 2019-2025.
This report focuses on Cardiac Monitoring & Cardiac Rhythm Management volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Monitoring & Cardiac Rhythm Management market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abiomed, Inc.
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardiac Science Corporation
General Electric Company (GE)
Hill-Rom Holdings, Inc.
Jarvik Heart, Inc.
Koninklijke Philips N.V.
LivaNova PLC
Medtronic plc
Nihon Kohden Corporation
ReliantHeart Inc.
SCHILLER AG
St. Jude Medical, Inc.
Siemens AG
3M Company
Asahi Kasei Corporation
Stryker Corporation
Mortara Instrument, Inc.
OSI Systems, Inc.
Cardionet Inc.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Electrocardiogram (ECG) Devices
Implantable Loop Recorders (ILR)
Cardiac Output Monitoring (COM) Devices
Event Monitors
Pacemakers
Cardiac Resynchronization Therapy (CRT) Devices
Defibrillator
External Defibrillator
Ventricular Assist Devices (VADs)
Segment by Application
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASCs)
Summary:
Get latest Market Research Reports on Cardiac Monitoring & Cardiac Rhythm Management . Industry analysis & Market Report on Cardiac Monitoring & Cardiac Rhythm Management is a syndicated market report, published as Global Cardiac Monitoring & Cardiac Rhythm Management Market Research Report 2019. It is complete Research Study and Industry Analysis of Cardiac Monitoring & Cardiac Rhythm Management market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.